About Aoife Gahlawat
Cancer Researcher & Project Lead based in Heidelberg, Germany.
15+ years experience in microRNAs, breast cancer, epigenetics, liquid biopsy and COVID-19 vaccines. My interest is in translational research, blood based biomarkers and cancer prevention.
Total circulating microRNA level as an independent prognostic marker for risk stratification in breast cancer
Channels contributed to:Behind the Paper
Great work, is this very specific to HCC? Have you tested other caner types`?